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In Brief
Metabolic remodeling underpins
inflammatory macrophage activation, but
the modulatory mechanisms are still
being elucidated. Bailey et al. show that
NO regulates specific changes in the
abundance of TCA cycle metabolites,
itaconate, and catalytic subunits of
Complex I in the respiratory chain in
inflammatory murine macrophages both
in vitro and in vivo.
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Classical activation of macrophages (M(LPS+IFNg))
elicits the expression of inducible nitric oxide syn-
thase (iNOS), generating large amounts of NO and in-
hibiting mitochondrial respiration. Upregulation of
glycolysis and a disrupted tricarboxylic acid (TCA)
cycle underpin this switch to a pro-inflammatory
phenotype. We show that the NOS cofactor tetrahy-
drobiopterin (BH4) modulates IL-1b production and
key aspects of metabolic remodeling in activated
murine macrophages via NO production. Using two
complementary genetic models, we reveal that NO
modulates levels of the essential TCA cycle metabo-
lites citrate and succinate, as well as the inflamma-
tory mediator itaconate. Furthermore, NO regulates
macrophage respiratory function via changes in the
abundance of critical N-module subunits in Complex
I. However, NO-deficient cells can still upregulate
glycolysis despite changes in the abundance of
glycolytic intermediates and proteins involved in
glucose metabolism. Our findings reveal a funda-
mental role for iNOS-derived NO in regulating meta-
bolic remodeling and cytokine production in the
pro-inflammatory macrophage.
INTRODUCTION
Macrophages classically activated by pro-inflammatory stimuli,
such as lipopolysaccharide (LPS) and interferon gamma (IFNg)
(M(LPS+IFNg)), undergo ametabolic switch that includes the up-
regulation of glycolysis, remodeling of the tricarboxylic acid
(TCA) cycle, and the inhibition of mitochondrial respiration (Kelly
and O’Neill, 2015). Central to the pro-inflammatory switch is the
expression of inducible nitric oxide synthase (iNOS), which gen-
erates large quantities of nitric oxide (NO) and requires tetrahy-
drobiopterin (BH4) as a cofactor (Tayeh and Marletta, 1989).218 Cell Reports 28, 218–230, July 2, 2019 ª 2019 The Author(s).
This is an open access article under the CC BY license (http://creativeThe NO generated is responsible for inhibiting mitochondrial
respiration by nitrosation of NADH dehydrogenase (Complex I)
of the electron transport chain (ETC) and reversible inhibition of
cytochrome c oxidase (Complex IV) (Chouchani et al., 2013;
Cleeter et al., 1994; Clementi et al., 1998; Van den Bossche
et al., 2016). Consequent upregulation of glycolysis and changes
in TCA cycle metabolic intermediates are pivotal determinants of
the macrophage inflammatory phenotype. For example, succi-
nate accumulation directs hypoxia-inducible factor 1a (HIF1a)-
mediated upregulation of glycolysis and interleukin-1b (IL-1b)
production, as well as driving reactive oxygen species (ROS)
generation (Mills et al., 2016; Tannahill et al., 2013). Elevated
succinate levels have been attributed to the citrate-derived
metabolite itaconate inhibiting succinate dehydrogenase (SDH)
(Cordes et al., 2016; Lampropoulou et al., 2016). Furthermore,
itaconate is an anti-inflammatory mediator that limits levels of in-
flammatory cytokines and has electrophilic properties that
modulate the IkBz-ATF3 inflammatory axis and NRF2 signaling
(Bambouskova et al., 2018; Lampropoulou et al., 2016). Eluci-
dating the mechanisms regulating metabolic pathways and the
balance of metabolites is vital for understanding macrophage
function, and we set out to investigate the roles of BH4 and NO
in regulatingmacrophagemetabolic remodeling following stimu-
lation with LPS and IFNg.
The requirement for BH4 in NOS-derived NO production is well
studied; however, we have shown non-cofactor roles for BH4 in
modulatingmitochondrial redox signaling in endothelial cells and
ROS generation in macrophages (Bailey et al., 2017; McNeill
et al., 2015). Furthermore, we recently demonstrated that BH4-
deficient macrophages show enhanced control of mycobacterial
infection in vitro relative to wild-type cells, whereas iNOS
knockout cells showed decreased control (McNeill et al.,
2018). This study not only highlighted a NOS-independent effect
of BH4 but also suggested, through transcriptomic analysis, dif-
ferences in the inflammatory response and cellular metabolism
relative to iNOS knockout cells (McNeill et al., 2018). In this
study, we therefore used bone-marrow-derived macrophages
(BMDMs) and thioglycolate-elicited peritoneal macrophages
from two complementary knockout models (Gch1, encodingcommons.org/licenses/by/4.0/).
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Figure 1. Proteomic Analysis of Upregulated Proteins Highlights BH4/NO Modulation of Inflammation, Mitochondrial Function, and
Metabolism
(A) Western blot analysis of iNOS and GTPCH protein levels in Gchfl/flTie2cre and iNOS KOBMDMs stimulated with LPS and IFNg for 16 h. b-Tubulin was used as
a loading control. sEnd.1 murine endothelial cells transfected with non-specific (NS) and GCH targeted siRNA were used as positive and negative controls for
GTPCH (n = 3).
(B) NOx (nitrite+nitrate) accumulation in the media measured using an NO analyzer (n = 5–6) (Black bars, Gch
fl/fl or WT; Red bars, Gchfl/flTie2cre; Blue bars,
iNOS KO).
(C) The abundance of GTPCH and iNOS proteins were determined by mass spectrometry (n = 4) and intracellular BH4 quantified using HPLC (n = 5–6).
(D) Number of proteins significantly (ANOVA, p < 9x106) changed in abundance as determined by mass spectrometric analysis (n = 4) and GO term enrichment
analysis of significantly upregulated proteins in Gchfl/flTie2cre BMDMs stimulated with LPS/IFNg. The most significant term in each cluster is annotated.
(E) Heatmap showing the scaled abundance of proteins identified in the mostly significantly enriched GO terms from the analysis of upregulated proteins.
(F) Il1b gene expression in Gchfl/flTie2cre and iNOSKO cells measured using qRT-PCR (n = 5) and levels of IL-1b in supernatants fromGchfl/flTie2cre and iNOSKO
cells measured by ELISA (n = 5).
Data are mean + SEM; p values calculated using 2-way ANOVA with Tukey’s post-test (*p < 0.05).the BH4 synthetic enzyme GTP cyclohydrolase [GTPCH], and
Nos2, encoding iNOS). These cells inherently lacked the capac-
ity to generate inducible NO, and we sought to investigate the ef-
fects of NO deficiency on bioenergetic metabolism in activated
macrophages while also investigating potential NO-independent
effects of BH4 depletion. We used a multi-‘‘omics’’ approach fol-
lowed by systematic validation studies to reveal that BH4 regu-
lates the abundance of catalytic Complex I subunits, levels
of itaconate, TCA cycle and glycolytic metabolites, as well as
IL-1b production through NO signaling.
RESULTS
Macrophages Lacking GTPCH or iNOS Do Not
Produce NO
To investigate the molecular pathways modulated by NO and
BH4 in M(LPS+IFNg) macrophages, we used Gch1-deficientBMDMs fromGchfl/flTie2cremice (McNeill et al., 2015).Gch1 en-
codes the protein GTPCH, which is the rate-limiting enzyme in
the synthesis of BH4. As BH4 is an essential cofactor for iNOS
function, resultant BH4 deficiency leads to macrophages that
are unable to produce NO, despite cytokine-induced expression
of the iNOS protein (Figures 1A, 1B, and 1C). Due to recent evi-
dence supporting a NOS-independent role for BH4 in cellular
redox signaling (Bailey et al., 2017; McNeill et al., 2015), we
also studied Nos2/ (iNOS knockout [KO]) BMDMs. These cells
have normal BH4 levels but are unable to generate NO (Figures
1A, 1B, 1C, and S1) and allow us to identify any NO-independent
effects of BH4 deficiency in macrophage activation. In addition,
we have used an NO donor (NOC-12) and iNOS inhibitor
(1400W) to further confirm certain NO-dependent affects.
NOC-12 was shown to significantly elevate NOx levels in media
from Gchfl/flTie2cre and iNOS KO M(LPS+IFNg) macrophages
(Figure 1B). Whereas, 1400W significantly decreased NOx levelsCell Reports 28, 218–230, July 2, 2019 219
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Figure 2. Proteomics Analysis of Downregulated Proteins Highlights BH4/NO Modulation of Mitochondria and Metabolism
(A) GO term enrichment analysis of significantly downregulated proteins in Gchfl/flTie2cre BMDMs stimulated with LPS/IFNg. The most significant term in each
cluster is annotated.
(B) Heatmap showing the scaled abundance of proteins identified in the mostly significantly enriched GO terms from the analysis of downregulated proteins (n = 4).
(C) mtDNA content was determined in Gchfl/flTie2cre and iNOS KO cells (n = 4).in media from Gchfl/fl and wild-type (WT) M(LPS+IFNg) cells
(Figure 1B).
Proteomic Analysis Reveals BH4-Mediated Modulation
of Inflammation, Mitochondrial Function, and
Metabolism
We used tandem mass tag (TMT)-labeling and whole-cell
proteomics analysis of Gchfl/flTie2cre macrophages and
Gchfl/fl controls to quantify the relative abundance of 5,704 pro-
teins in unstimulated and LPS/IFNg-activated cells (PRIDE:
PXD010628). We observed the expected changes in GTPCH
and iNOS protein abundance (Figures 1A and 1C), demon-
strating the validity of the experimental model, and revealed
that a select number of proteins differed significantly according
to genotype (Figure 1D). Gene Ontology (GO) term enrichment
analysis of the 94 proteins that were significantly increased in
M(LPS+IFNg) Gchfl/flTie2cre versus Gchfl/fl macrophages identi-
fied an upregulation of proteins involved in the response to inter-
feron-b (IFN-b), production of IL-1b, antigen presentation, and
subunits of mitochondrial respiratory chain Complex I (Figures
1D and 1E). These results suggested both an enhanced
response to, and synthesis of, specific inflammatory cytokines
in BH4-deficient macrophages and a potential mechanism link-
ing absence of BH4 and NO to the maintenance of Complex I
function.
To confirm that M(LPS+IFNg) BH4-deficient macrophages
were producing more of IL-1b, we measured Il1b mRNA
and IL-1b secretion and found striking elevations in both220 Cell Reports 28, 218–230, July 2, 2019(Figure 1F). This increased Il1b mRNA and IL-1b secretion
was also found in M(LPS+IFNg) iNOS KO cells, indicating
that it occurred due to the loss of NO signaling (Figure 1F)
and appears to be selective as levels of tumor necrosis factor
alpha (TNFa), IL-6, and IL-10 were maintained in NO-deficient
cells (apart from a small decrease in IL-6 in stimulated
Gchfl/flTie2cre as previously reported [McNeill et al., 2015])
(Figure S2). The fact that NO regulates IL-1b production was
further supported by significantly decreased IL-1b in
M(LPS+IFNg) NO-deficient cells treated with NOC-12 and
elevated IL-1b in M(LPS+IFNg) Gchfl/fl and WT treated with
1400W (Figure 1F).
Enrichment analysis of the 55 decreased proteins highlighted
additional mitochondrial and metabolic changes, and showed
downregulated proteins involved in the mitochondrial ribosome,
mitochondrial gene expression, and carbohydrate metabolism
(Figures 2A and 2B). However, analysis of mtDNA content in
Gchfl/flTie2cre and iNOS KO cells indicated no significant
changes in mitochondrial content (Figure 2C). Interestingly,
metabolic enzymes such as the glucose transporter member 1
(GLUT-1), squalene synthase, fatty acid desaturase-2, andCom-
plex I subunits (Ndufs6 and Ndufa12) were among the 20 most
significantly changed proteins (Figure S3). Taken together, these
results implicated BH4 in the modulation of several aspects of
metabolism, mitochondrial function, and inflammation, but
whether mitochondrial and metabolic changes resulted from
loss of NO signaling remained to be confirmed and became
the focus of further investigation.
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Figure 3. NO-Dependent Inhibition of NADH Dehydrogenase and Mitochondrial Respiration
(A) Structure of the modules (N, Q, PP, and PD) making up NADH dehydrogenase (Complex I).
(B) Fold change of N module subunits relative to unstimulated Gchfl/fl cells (n = 4, * denotes subunits not significantly changed by ANOVA).
(C) Ndufv2 protein levels determined by western blotting in Gchfl/flTie2cre and iNOS KO cells (n = 4).
(D) Ndufv2 mRNA levels determined by qRT-PCR in Gchfl/flTie2cre and iNOS KO cells (n = 5).
(E) Complex I (labeled I) in gel activity assay with digitonin to demonstrate supercomplex (SC) abundance and DDM (n-dodecyl-b-D-maltoside) to demonstrate
isolated complex I activity in Gchfl/flTie2cre cells.
(F andG) Oxygen consumption rate (OCR) wasmeasured using XFe96 Seahorse bioanalyzer with compounds used to determine basal, ATP-linked andmaximum
respiration in (F) Gchfl/flTie2cre (black solid line, unstimulated Gchfl/fl; red solid line, unstimulated Gchfl/flTie2cre; black dashed line, M(LPS+IFNg) Gchfl/fl; red
dashed line, M(LPS+IFNg) Gchfl/flTie2cre cells) and (G) iNOS KO macrophages (black solid line, unstimulated WT; blue solid line, unstimulated iNOS KO; black
dashed line, M(LPS+IFNg) WT; blue dashed line, M(LPS+IFNg) iNOS KO cells) (n = 5–6).
Data are mean + SEM; p values calculated using 2-way ANOVA with Tukey’s post-test (*p < 0.05).NO Regulates Complex I Function and Mitochondrial
Respiration
One of the most striking changes highlighted by the proteomic
analysis were changes in several subunits of Complex I, an
intricate protein of almost 1,000 kDa, comprising 44 subunits(Guerrero-Castillo et al., 2017). Situated in the mitochondrial in-
ner membrane, Complex I is formed of 4 distinct modules (Fig-
ure 3A), and our data revealed significant co-ordinated de-
creases in 5 out of 8 subunits making up the catalytic NADH
binding module (N-module) in stimulated Gchfl/fl cells, withCell Reports 28, 218–230, July 2, 2019 221
another 2 subunits (Ndufs4 and Ndufv1) showing a similar
pattern but they were not statistically significant (Figure 3B).
Upon activation, these decreases were largely attenuated by
the absence of BH4 and NO in Gch
fl/flTie2cre cells—including
in the 3 subunits (Ndufv1, Ndufv2, and Ndufs1) thought to be
essential for catalysis. Western blot analysis of Ndufv2 in Gchfl/fl
and WT cells confirmed depletion of this protein upon stimula-
tion, and the fact that both Gchfl/flTie2cre and iNOS KO
M(LPS+IFNg) cells retained much greater levels indicated that
this was driven by NO (Figure 3C). Furthermore, treatment of
Gchfl/flTie2cre and iNOS KO M(LPS+IFNg) cells with NOC-12
led to substantially decreased Ndufv2 protein, whereas Gchfl/fl
and WT M(LPS+IFNg) cells treated with 1400W retained Ndufv2
(Figure 3C). Significantly reduced expression of Ndufv2 in stimu-
lated Gchfl/fl and WT cells suggested that changes in protein
levels may result from NO-dependent transcriptional regulation,
and restored gene expression in iNOS KOwould support this hy-
pothesis (Figure 3D). However, gene expression in M(LPS+IFNg)
Gchfl/flTie2cre cells was repressed, suggesting involvement of
other mechanisms and highlighting a difference between BH4-
replete and -deficient cells. An in-gel activity assay confirmed
that Complex I activity was decreased in Gchfl/fl M(LPS+IFNg)
cells but maintained in Gchfl/flTie2cre M(LPS+IFNg) cells and
also showed that stimulatedGchfl/fl cells had a reduction in Com-
plex I-containing supercomplexes (Figure 3E). These differences
were paralleled by changes in oxygen consumption rate (OCR),
as basal and ATP-linked respiration were largely maintained in
activated cells unable to produce NO in Gchfl/flTie2cre and
iNOS KO, in contrast to the well-established NO-induced inhibi-
tion of respiration in Gchfl/fl and WT cells (Figures 3F and 3G).
Although maximum respiration was also significantly higher in
stimulated NO-deficient cells, this remained no higher than basal
levels and significantly lower than unstimulated cells, indicating
changes in respiratory capacity that occur after stimulation but
by NO-independent mechanisms. These results concur with pre-
vious reports that NO modulates Complex I activity and the
metabolic switch away from oxidative metabolism in activated
macrophages and additionally demonstrates a fundamental
and important role for NO in modulating Complex I subunit
abundance.
Glycolytic Rate Is Unchanged in the Absence of NO
despite Changes in the Abundance of Glycolytic
Metabolites and Proteins
The switch from oxidative phosphorylation to glycolysis-medi-
ated ATP synthesis is a well-established characteristic of
M(LPS+IFNg) macrophages (Kelly and O’Neill, 2015). It is
directed by increased levels of key proteins under the transcrip-
tional control of HIF1a, including GLUT-1, hexokinase-2,
and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3
(PFKFB3) (Liu et al., 2016;Wang et al., 2017). We observed these
same changes in M(LPS+IFNg) WT macrophages that produce
NO (Figures 4A and B). However, in M(LPS+IFNg) Gchfl/flTie2cre
macrophages, GO term enrichment analysis highlighted
comparatively fewer of the enzymes related to ‘‘starch and su-
crose metabolism,’’ including glycolytic enzyme hexokinase-2
and proteins directing glycogen storage and release (Figures
2A and 2B). Furthermore, a refined search of the data from222 Cell Reports 28, 218–230, July 2, 2019Gchfl/flTie2cre macrophages revealed changes in several other
proteins involved in glucose metabolism and glycolysis (Figures
4A and 4B), including significant decreases in GLUT-1, hexoki-
nase-1, and PFKFB3, along with increases in hexokinase-3,
triose phosphate isomerase, phosphoglycerate kinase, and
glycerol-catabolising enzymes (Figures 4A and 4B). To explore
the consequences of these changes in protein abundance and
whether they were dependent on changes in NO signaling, we
used mass spectrometry to measure metabolites in macro-
phages from Gchfl/flTie2cre and iNOS KO mice (Figures S4 and
S5; Tables S1 and S2). We found marked changes in the abun-
dance of certain glycolytic intermediates in NO-deficient versus
-replete M(LPS+IFNg) cells (Figures 4C and 4D), as well as the
glycerol metabolite glycerol-3-phosphate that feeds into this
pathway (Table S3). The relative changes in metabolite
abundance were very similar in stimulated Gchfl/fl versus
Gchfl/flTie2cre and WT versus iNOS KO cells, indicating that
these BH4-induced changes resulted from the loss of NO. In
earlier parts of the glycolysis pathway, there was less fructose-
1,6-bisphosphate and dihyroxyacetone-phosphate in NO-defi-
cient cells; however, in later steps there was a small increase
of 3-phosphoglycerate (only in Gchfl/flTie2cre) and no difference
in levels of the later products of glycolysis, phosphoenolpyr-
uvate, and pyruvate (Figures 4E and S6).
The product of glycolysis, pyruvate, is converted into lactate or
oxidized in the TCA cycle, and both lead to acidification of the
media through proton extrusion, which can be used to estimate
glycolytic activity. Intracellular lactate was increased in NO-
replete M(LPS+IFNg) cells but to a lesser extent in the absence
of NO (Figures 4C, 4D, and 4E), and this was similarly observed
for extracellular lactate accumulation (Figure 4F). Interestingly,
the extracellular acidification rate (ECAR) resulting from glucose
oxidation was elevated in all M(LPS+IFNg) cells regardless of
BH4 or NO levels (Figure 4G). To investigate the proportional ef-
fects of lactate versus TCA acidification, the glycolytic proton
efflux rate (glycoPER) and percentage PER attributed to glycol-
ysis were calculated in Gchfl/fl versus Gchfl/flTie2cre cells (Fig-
ure 4H). This confirmed that glycoPER—and thus glycolytic
rate—was equally elevated in NO-synthesizing and NO-deficient
M(LPS+IFNg) cells and that glycolysis was the major contributor
to PER at > 90% in M(LPS+IFNg) cells, which was significantly
higher than in non-stimulated cells (Figure 4H). In addition,
glucose uptake was similarly elevated in M(LPS+IFNg) macro-
phages of all genotypes (Figure 4I).
To validate proteomic changes observed in M(LPS+IFNg)
Gchfl/flTie2cre cells and their dependence on NO, we measured
expression of the gene encoding GLUT-1 (Slc2a1) and the
amount of hexokinase-2 protein in Gchfl/flTie2cre and iNOS KO
cells. This showed a failure to induce transcription of Slc2a1 (Fig-
ure 4J) and decreased levels of hexokinase-2 protein (Figure 4K)
in both Gchfl/flTie2cre and iNOS KO cells. Interestingly, several
proteins of lower abundance in activated cells unable to produce
BH4 and NOwere those that were previously reported to be tran-
scriptionally regulated by HIF1a (Table S4). We therefore used
western blot analysis to determine whether previously reported
LPS-stimulated HIF1a stabilization was disrupted in the absence
of BH4 and NO and found a lower abundance of HIF1a in
Gchfl/flTie2cre cells (Figure 4K). HIF1a was like-wise decreased
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Figure 4. Glycolytic Rate Is Unaffected by Loss of NO Signaling Despite Changes in the Levels of Glycolytic Proteins and Metabolites
(A) Heatmap showing fold changes in abundance of enzymes significantly changed relative to Gchfl/fl unstimulated cells (n = 4, p < 0.05, *PFKB3 = fold change > 3).
(B) Abundance of PFKFB3 protein (n = 4).
(C and D) (C) Fold change heatmaps of significantly changed (p > 0.05) metabolites relative to unstimulated Gchfl/fl or (D) unstimulated WT cells (n = 6).
(E) Glucose metabolism pathway representing changes (>20%) in abundance of enzymes and metabolites in LPS/IFNg stimulated Gchfl/flTie2cre versus Gchfl/fl
macrophages.
(F) Lactate accumulation measured in medium supernatants from macrophages following overnight stimulation (n = 4).
(G) Basal glycolysis determined using 2-deoxyglucose inhibitable ECARmeasured using XFe96 Seahorse bioanalyzer in Gchfl/flTie2cre and iNOS KO cells (n = 6).
(H) Basal glycolytic rate determined in Gchfl/flTie2cre cells by calculating glycolytic proton efflux rate (glycoPER) (n = 3).
(H) The contribution of glycolysis to acidification of media in Gchfl/flTie2cre cells (n = 3).
(I) Measurement of glucose uptake in Gchfl/flTie2cre and iNOS KO cells (n = 4).
(J) qRT-PCR mRNA measurement of Slc2a1 gene encoding GLUT-1 protein in Gchfl/flTie2cre and iNOS KO cells (n = 5).
(K) Western blot analysis of HIF1a and hexokinase 2 proteins in Gchfl/flTie2cre and iNOS KO cells (n = 4).
Data are mean + SEM; p values calculated using 2-way ANOVA with Tukey’s post-test (*p < 0.05).in iNOS KO cells and implicated loss of NO signaling (Figure 4K).
Overall glycolysis is sufficiently upregulated in M(LPS+IFNg)
cells irrespective of BH4 or NO levels, despite changes in levels
of several glycolytic metabolites and proteins involved in glucose
metabolism.
NO Regulates Levels of Critical TCA Cycle Metabolites
and Itaconate
Accumulation of TCA cycle metabolites citrate, succinate, and
fumarate, as well as itaconate, is a hallmark of metabolic reprog-
ramming of inflammatory macrophages (Arts et al., 2016; Infan-
tino et al., 2011; Mills et al., 2018; Tannahill et al., 2013). Using
untargeted metabolomics, we compared knockout models
with controls and observed the predicted elevations in our stim-
ulated NO-producing (Gchfl/fl andWT)macrophages (Figures 5A,
5B, 5C, S4, and S5). However, stimulated cells lacking NO
(Gchfl/flTie2cre and iNOS KO) even in the presence of BH4(iNOS KO) showed significantly elevated succinate (1.6-fold)
but markedly less citrate, revealing an important effect of NO
on inflammatory metabolites (Figures 5A, 5B, 5G, S4, and S5).
Itaconate was also elevated 2.5-fold more in M(LPS+IFNg) NO-
deficient cells (Figure 5C). Itaconate is synthesized from citrate
through the intermediate cis-aconitate by the enzyme cis-aconi-
tate decarboxylase encoded by Irg1 (Michelucci et al., 2013). We
therefore examined whether increased levels of cis-aconitate
decarboxylase could underlie the elevated itaconate but found
no difference in protein levels in M(LPS+IFNg) Gchfl/fl versus
Gchfl/flTie2cre cells by mass spectrometry (Figure 5D). This
was confirmed by western blot analysis of cis-aconitate decar-
boxylase in both Gchfl/flTie2cre and iNOS KO cells (Figure 5E)
and occurred despite finding increased induction of Irg1 tran-
script in stimulated Gchfl/flTie2cre and iNOSKO cells (Figure 5G).
Elevated itaconate levels were confirmed in M(LPS+IFNg)
Gchfl.flTie2cre and iNOS KO cells compared with NO-repleteCell Reports 28, 218–230, July 2, 2019 223
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Figure 5. NO Modulates Levels of TCA Cycle Metabolites and Itaconate
(A and B) Fold change heatmaps of significantly changed (p < 0.05) metabolites relative to (A) Gchfl/fl or (B)WT unstimulated cells (n = 6, *itaconate fold change > 8)
as measured using mass spectrometry.
(C) Itaconate metabolite abundance in Gchfl/flTie2cre and iNOS KO cells measured using mass spectrometry (n = 6).
(D) Abundance of cis-aconitate decarboxylase protein in Gchfl/flTie2cre cells measured using mass spectrometry (n = 4).
(E) Western blot analysis of cis-aconitate decarboxylase (IRG1), iNOS, and GTPCH protein (n = 4). b-tubulin was used as a loading control.
(F) Irg1 gene expression in Gchfl/flTie2cre and iNOS KO cells (n = 5).
(G) TCA cycle pathway showing changes (>20%) in abundance of enzymes and metabolites in LPS/IFNg stimulated Gchfl/flTie2cre versus Gchfl/fl macrophages.
(H) Itaconate measured using HPLC in Gchfl.flTie2cre and iNOS KO cells treated with 1400W and NOC-12 (n = 4).
Data are mean + SEM; p values calculated using 2-way ANOVA with Tukey’s post-test (*p < 0.05).cells using high-performance liquid chromatography (HPLC)
analysis (Figure 5H). In addition, HPLC analysis of M(LPS+IFNg)
Gchfl/fl and WT cells treated with 1400W showed significantly
elevated itaconate, whereas NO donor treatment of all cells
had no effect (Figure 5H).
Elevated citrate has previously been attributed to transcrip-
tional repression of Idh1 (Jha et al., 2015), and we therefore
considered disruption of this ‘‘break point’’ as a potential cause
of the depletion in citrate in the absence of NO. In accordance
with previous reports (Jha et al., 2015; Tannahill et al., 2013), we
did find repression of Idh1 and Idh2 gene expression in stimu-
lated NO-synthesizing cells and also observed this in stimu-
lated Gchfl/flTie2cre and iNOS KO cells (Figures 6A and 6B).
However, our proteomics data revealed that isocitrate dehy-
drogenase (IDH1) and IDH2 protein levels were unchanged by
LPS/IFNg stimulation (Figure 6C)—irrespective of BH4 or NO
production—and this was confirmed by western blotting for
IDH1 (Figure 6D). IDH protein levels do not therefore explain
changes in citrate in our model, nor underlie this ‘‘break point.’’
In fact, we found no differences in the abundance of any TCA
cycle enzymes in M(LPS+IFNg) cells in the absence of BH4224 Cell Reports 28, 218–230, July 2, 2019and NO (Figure S7), leading to the hypothesis that changes in
their activity could account for the observed impact on metab-
olite levels. We therefore measured selected enzyme activities,
which revealed significantly decreased IDH1 and IDH2 activity
in stimulated WT but not Gchfl/flTie2cre and iNOS KO cells
compared with unstimulated Gchfl/fl or WT macrophages (Fig-
ure 6E). Interestingly, we also observed significantly decreased
nitrosation at cysteine-133 in M(LPS+IFNg) Gchfl/flTie2cre
macrophages compared with Gchfl/fl cells and significantly
decreased nitrosation of cysteines-113, 154, and 418 in
M(LPS+IFNg) iNOS KO versus WT cells (Figure 6F). Further-
more, treatment of WT unstimulated macrophages with the
IDH inhibitor GSK864 led to notable elevations in both citrate
and itaconate (Figure 6G). Proteomics data showed a small
but significant decrease in aconitase 1 protein in M(LPS+IFNg)
cells (Figure 6H), and dramatically decreased aconitase 1 and 2
activity was apparent in stimulated cells (Figure 6H), but these
results were irrespective of BH4 and NO production. Taken
together, these results suggest that IDH but not aconitase ac-
tivity is a key determinant of NO-dependent changes in TCA
metabolites.
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Figure 6. NO Modulates IDH Activity
(A) Idh1 gene expression in Gchfl/flTie2cre and iNOS KO cells (n = 5).
(B) Idh2 gene expression in Gchfl/flTie2cre and iNOS KO cells (n = 5).
(C) IDH1 and IDH2 protein abundance measured using mass spectrometry in Gchfl/flTie2cre cells (n = 4).
(D) Western blot analysis of IDH1 protein in Gchfl/flTie2cre and iNOS KO cells (n = 3).
(E) IDH1 and IDH2 combined activity in Gchfl/flTie2cre and iNOS KO cells (n = 3).
(F) Normalized abundance of IDH peptides containing nitrosated cysteine residues, in samples from Gchfl/flTie2cre and iNOS KO macrophages (n = 4).
(G) Citrate and itaconate levels in WT unstimulated macrophages treated with the IDH inhibitor GSK864 (n = 4).
(H) Abundance of aconitase 1 protein measured using mass spectrometry (n = 4) and aconitase 1 and 2 activity in Gchfl/flTie2cre cells (n = 3–5).
Data are mean + SEM; p values calculated using 2-way ANOVA with Tukey’s post-test (*p < 0.05).NO-Deficient Peritoneal Macrophages Derived In Vivo
Have Increased Itaconate and IL-1b
To see if the major results frommacrophages differentiated from
bone marrow precursor cells with colony-stimulating factors
(CSFs) in vitro could be recapitulated from cells derived in vivo,
we measured itaconate and IL-1b levels in thioglycolate-elicited
peritoneal macrophages from both our murine models of NO
deficiency. Fluorescence-activated cell sorting (FACS) analysis
of freshly isolated peritoneal macrophages showed a high per-
centage of CD11+/F4/80+ cells, indicative of a relatively pure
macrophage population (Figures 7A and 7B). We observed the
expected inductions of iNOS protein in M(LPS+IFNg) Gchfl/fl,
Gchfl/flTie2cre, andWT cells but not iNOS KO cells, and elevated
GTPCH in all M(LPS+IFNg) cells apart from Gchfl/flTie2cre (Fig-
ure 7C). NOx was significantly decreased and barely detectable
in Gchfl/flTie2cre and iNOS KO macrophages, respectively(Figure 7D). In M(LPS+IFNg) macrophages from both
Gchfl/flTie2cre and iNOS KO models, itaconate was increased
2.5-fold compared to control (Figure 7E), despite unchanged
amounts of IRG1 protein (Figure 7C). Similarly, levels of IL-1b
were increased significantly in peritoneal macrophages deficient
of NO (Figure 7F). While not exhaustive, these measures prove
that the NO-dependent changes in immuno-metabolism and
cytokine production in BMDMs are not simply artifacts of
in vitro differentiation with CSFs.
BH4- and NO-Deficient Macrophages Lead to Elevated
Itaconate Accumulation in Two Distinct Models of
Infection and Acute Inflammation In Vivo
Having demonstrated the NO-dependent modulation of the key
anti-inflammatory metabolite itaconate in BMDMs, we aimed
to recapitulate this key metabolic phenotype in vivo. First,Cell Reports 28, 218–230, July 2, 2019 225
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Figure 7. NO Modulates Levels of Itaconate in M(LPS+IFNg) Peritoneal Macrophages, Mice Infected with BCG, and Mice Experiencing
LPS-Induced Acute Endotoxaemia
(A) FACS analysis of peritoneal macrophages isolated from Gchfl/flTie2cre and iNOS KO mice.
(B) The percentage of CD11b+/F4:80+ peritoneal macrophages isolated from Gchfl/flTie2cre and iNOS KO mice measured using FACS (n = 4).
(C) Western blot analysis of iNOS, IRG1 and GTPCH protein in peritoneal macrophages stimulated with LPS/IFNg (n = 4). b-tubulin was used as the loading
control.
(D) NOx measurements in medium supernatants from stimulated Gch
fl/flTie2cre and iNOS KO peritoneal macrophages (n = 4).
(E) Itaconate measured by HPLC in stimulated Gchfl/flTie2cre and iNOS KO peritoneal macrophages (n = 4). (F) IL-1b secreted from stimulated Gchfl/flTie2cre and
iNOS KO peritoneal macrophages (n = 4).
(G) Itaconate measured by HPLC in lung tissue from Gchfl/flTie2cre mice infected with BCG (n = 4–12).
(H–J) (H) BH4 (H), NOx (I), and itaconate (J) measured in lung tissue from Gch
fl/flTie2cre mice treated with 12.5 mg/kg LPS to induce acute endotoxaemia (n = 6).
Data are mean + SEM; p values calculated using 2-way ANOVA with Tukey’s post-test (*p < 0.05).Gchfl/flTie2cre mice were infected with Mycobacterium bovis
Bacillus Calmette Guerin (BCG) and previously demonstrated
to be deficient in BH4 and NOx (McNeill et al., 2018); we reveal
that lungs from Gchfl/flTie2cre mice also exhibit significantly
elevated itaconate levels following BCG infection compared to
WT (Figure 7G). Second, to more directly parallel our in vitro
LPS activation, we then analyzed lung tissue taken from mice
following LPS-induced endotoxaemia in vivo (Figure S8); lung
tissue was analyzed and the levels of BH4 and NOx were
confirmed to be decreased in tissues from LPS treated
Gchfl/flTie2cre versus Gchfl/fl mice (Figures 7H and 7I). Further-
more, in support of our findings in LPS-stimulated BMDMs and
peritoneal macrophages ex vivo, LPS-induced endotoxaemia
led to significantly elevated itaconate levels in lung tissue from
NO-deficient Gchfl/flTie2cre animals (Figure 7J). Together, these
data demonstrate the translation of our in vitro analyses to
confirm that BH4 and NO levels modulate itaconate accumula-
tion in vivo.
DISCUSSION
It is well established that BH4 is required for generation of NO by
iNOS in macrophages responding to inflammatory stimuli, and
this is important for the destruction of pathogens, as part of
the innate immune response. More recently, metabolic remodel-
ing in macrophages has been recognized as a pivotal part of the
pro-inflammatory switch, including the NO-mediated inhibition226 Cell Reports 28, 218–230, July 2, 2019of mitochondrial oxidative phosphorylation. In the current study,
we have shown that BH4 modulates specific metabolic changes
in inflammatory macrophages by the regulation of NO produc-
tion. These include regulating respiratory function by changes
in the abundance of critical N-module subunits in Complex I
and changes in levels of the important TCA cycle metabolites
(and inflammatory mediators) citrate, succinate, and itaconate.
Taken together, we have demonstrated that inducible NO has
a fundamental role in metabolic remodeling upon activation of
macrophages.
Metabolic changes are intricately linked with the switch to a
pro-inflammatory phenotype in macrophages, including the crit-
ical ‘‘Warburg’’-like shift from oxidative metabolism to glycolytic
ATP generation. NO is known to modulate ETC activity through
nitrosation of Complex I and competitive inhibition of
O2-consuming Complex IV (Chouchani et al., 2013; Cleeter
et al., 1994) and is responsible for inhibiting oxidative phosphor-
ylation in both activatedmacrophages and dendritic cells (Everts
et al., 2012; Van den Bossche et al., 2016). In accordance with
these studies, we observed NO-dependent inhibition of Com-
plex I and mitochondrial respiration. In addition, we have
expanded the repertoire of NO-dependent mechanisms govern-
ing the ETC to include regulating the abundance of proteins
making up the NADH-binding catalytic module (N-module) of
Complex I. We propose that, upon stimulation, loss of essential
N-module subunits renders Complex I incapable of binding and
accepting electrons from NADH—thereby providing an insight
into the mechanisms that modulate the metabolic switch away
from oxidativemetabolism in activatedmacrophages. AsNdufv2
mRNA was decreased in NO-synthesizing macrophages but
maintained in iNOS KO cells, we hypothesize that NO regulates
transcription of these subunits by an unknown mechanism.
However, it is also possible that NO modulates the stability of
these subunits, which are exposed in the mitochondrial matrix
and might be sensitive to nitrosation.
Inhibition of mitochondrial respiration is not essential for
macrophages to maintain their inflammatory polarization (Van
den Bossche et al., 2016), in contrast with glycolysis that is up-
regulated and required for inflammatory cell survival and cyto-
kine production (Krawczyk et al., 2010; Tannahill et al., 2013). In
our NO-deficient M(LPS+IFNg) macrophages, we found the
expected elevation of glycolytic rates despite decreased abun-
dance of several key proteins involved in glucose metabolism
(GLUT-1, hexokinase-1 and 2, and PFKFB3) and the intracel-
lular glycolytic metabolites fructose-1,6-bisphosphate, DAHP,
and lactate. It was interesting to observe that extracellular
lactate levels were also decreased, as this would usually corre-
late with glycolytic rates derived from extracellular acidification
(Mookerjee et al., 2015). However, as glycolytic rate was deter-
mined at the point in time after overnight stimulation, whereas
extracellular lactate measurements included accumulations
overnight, our data might suggest that the time course for upre-
gulating glycolysis is altered in NO-deficient M(LPS+IFNg)
cells.
In light of our results showing decreased levels of GLUT-1
and key glycolytic regulatory proteins (hexokinase-2 and
PFKFB3), which are usually upregulated in NO-proficient in-
flammatory macrophages, it is important to consider alternate
mechanisms upregulating glycolysis in NO-deficient cells.
Although these protein changes appear to have inhibited the
earlier part of glucose oxidation, causing decreased fructose-
1,6-bisphosphate, increased abundance of triose phosphate
isomerase, phosphoglycerate kinase, and 3-phosphoglycerate
may indicate compensatory increased metabolism further
along the pathway. In support of this, it is possible for metab-
olites from the pentose phosphate pathway and glycerol catab-
olism to feed in through dihydroxyacetone phosphate and
glycerol-3-phosphate, and we have indications of increased
glycerol metabolism through increased abundance of catabolic
enzymes and decreased levels of glycerol-3-phosphate. Future
studies will be interesting to dissect this, as well as the precise
mechanisms behind these changes. In this report, we noted
that several of the decreased proteins in our KO cells were
known to be transcriptionally induced by HIF1a in WT inflam-
matory macrophages (Liu et al., 2016; Wang et al., 2017).
Upon also observing decreased HIF1a in NO-deficient cells,
we speculate that this may be one reason. NO has previously
been shown to increase the stability and activity of HIF1a under
non-hypoxic conditions (Kasuno et al., 2004; Sandau et al.,
2001; Sumbayev et al., 2003), so this is a plausible hypothesis.
However, as HIF1a levels are also modulated by molecules that
include succinate, 4-octyl itaconate, and ROS, it is clear that
we must consider that other such secondary changes are
mechanistically responsible (Mills et al., 2016, 2018; Selak
et al., 2005; Tannahill et al., 2013).Accumulation of specific TCA cycle metabolites in activated
macrophages has led to the discovery of their function in modu-
lating inflammation (Arts et al., 2016; Infantino et al., 2011; Tan-
nahill et al., 2013). Carbon flux analyses have identified two
‘‘breaks’’ in the cycle, at IDH and SDH (Jha et al., 2015), leading
to elevations in citrate and succinate, respectively, and this was
reproduced in our activated NO-synthesizing cells. A study iden-
tifying transcriptional repression of Idh1 has suggested this as
the reason for redirection of citrate into lipid and itaconate syn-
thesis rather than isocitrate metabolism (Jha et al., 2015).
Here, we also measured marked decreases in transcription of
Idh1 as well as Idh2, although our analysis revealed no subse-
quent changes in IDH protein levels. We also demonstrated
that IDH and aconitase enzyme activities are dramatically
decreased and therefore more likely to be responsible for the
accumulation of citrate. Furthermore, we have shown that citrate
levels are modulated by NO, as citrate was no longer elevated in
macrophages incapable of producing NO. Although aconitase
activity was decreased, IDH activity was maintained in NO-defi-
cient M(LPS+IFNg) cells and provides a possible avenue utilizing
citrate in addition to increased itaconate production. This poten-
tially explains the lack of citrate accumulation and is plausible, as
NO has previously been shown to inhibit IDH activity through ni-
trosation (Lee et al., 2003; Yang et al., 2002), which was also
shown to be decreased at several cysteine residues in NO-defi-
cient M(LPS+IFNg) cells.
Itaconate is one of the most highly induced metabolites
following activation of BMDMs (Lampropoulou et al., 2016; Mills
et al., 2018), and we have observed a 2.5-fold elevation in NO-
deficient M(LPS+IFNg) cells compared to NO-replete cells. In
support of this finding, itaconate was shown to be elevated in
WT cells treated with 1400W to decrease NO generation. Con-
trastingly, treatment of NO-deficientM(LPS+IFNg) macrophages
with a NO donor had no effect, possibly due to the inability of
NOC-12 to enter the mitochondria and reach the intracellular
target required to alter itaconate levels. Notably, we have also
demonstrated the relevance of our in vitro findings by using
in vivo models of BCG infection and LPS-induced endotoxae-
mia, where elevated itaconate levels were observed in lung tis-
sues from leukocyte specific BH4-deficient animals. Overall,
these data suggest that NO canmodulate inflammatory signaling
by regulating itaconate levels, as itaconate is proven to be bacte-
ricidal but also an anti-inflammatory mediator (Bambouskova
et al., 2018; Lampropoulou et al., 2016). Unchanged levels of
the synthetic enzyme cis-aconitate decarboxylase indicated
that increased itaconate could result from changes in enzyme
activity, but as metabolites were only measured intracellularly,
it may also be due to changes in itaconate release. It is also
possible that the elevated protein response to IFNb highlighted
by our proteomics data is directing elevated itaconate produc-
tion in NO-deficient cells, as Type I IFNs were shown to stimulate
itaconate production in several studies (Mills et al., 2018; Nau-
joks et al., 2016; Tallam et al., 2016). Itaconate may also account
for elevated succinate levels in our BH4 and NO-deficient cells,
as it is a proven inhibitor of SDH and leads to accumulation of
succinate in stimulated macrophages (Cordes et al., 2016;
Lampropoulou et al., 2016). This is another mechanism by which
itaconate directs inflammatory signaling as succinate modulatesCell Reports 28, 218–230, July 2, 2019 227
HIF1a-mediated IL-1b production and drives mitochondrial ROS
generation (Mills et al., 2016; Tannahill et al., 2013). However,
changes in succinate release are also a potential mechanism ac-
counting for differences in intracellular levels.
The key pro-inflammatory mediators TNFa, IL-6, and IL-1b
were all induced in activated NO-deficient as well as NO-synthe-
sizing cells; however, IL-1b secretion was elevated alongside the
abundance of proteins making up the inflammasome complex
(NLRP3, AIM2, and caspase-1). The inflammasome cleaves
pro-IL-1b into its mature secreted form, and NO is known to
inhibit this complex through nitrosation (Hernandez-Cuellar
et al., 2012; Mao et al., 2013; Mishra et al., 2013); thus the loss
of NO signaling and decreased nitrosation of the inflammasome
are likely to contribute to upregulated IL-1b secretion. In addi-
tion, the observed increased abundance of inflammasome pro-
teins and transcription of Il1bmust occur throughNO-dependent
and as yet unidentified mechanisms. HIF1a transcriptionally reg-
ulates Il1b in stimulated macrophages (Tannahill et al., 2013);
however, as discussed, HIF1a is decreased in our models and
so does not explain this finding. It is interesting to note that
although Il1b gene expression was previously shown to be lower,
it was still induced in HIF1a KO macrophages stimulated with
LPS, thus suggesting that other mechanisms induce the expres-
sion of this gene and they warrant further study. More recently,
NRF2 signaling was shown to repress IL-1b production in mac-
rophages (Mills et al., 2018), and our group has previously
demonstrated disrupted NRF2 signaling in stimulated macro-
phages devoid of NO due to BH4 deficiency (Douglas et al.,
2018; McNeill et al., 2015). NO-dependent changes in this
pathway potentially determine increased Il1b transcription.
It is important to consider the potential translational relevance
of our murine data in the human setting. It is well established that
human macrophages do not produce such a fulminant NO
response under many conditions of activation (Fang and Vaz-
quez-Torres, 2002; Schneemann and Schoedon, 2002; Schnee-
mann et al., 1993; Sharara et al., 1997; Vouldoukis et al., 1995).
Part of this difference is in fact driven by their relatively low BH4
content, due to exon skipping in the PTPS gene leading to a
reduction in 6-pyruvoyl tetrahydropterin synthase (PTPS) in the
BH4 biosynthetic pathway (Leitner et al., 2003). Understanding
how metabolic remodeling is altered in inflammatory macro-
phages in the context of low and high BH4/NO therefore has pro-
found implications for human macrophage biology and disease,
andmodels such as theGchfl/flTie2cre knockoutmicemay in fact
provide a better reflection of human biology.
In summary, growing evidence links metabolism to the pro-
duction of inflammatory mediators (Mills et al., 2016, 2018; Tan-
nahill et al., 2013), and in this study, we report that BH4 modu-
lates metabolic remodeling and immuno-metabolism through
themodulation of NO signaling inmurinemacrophages respond-
ing to inflammatory stimuli, both in vitro and in vivo. It is important
to consider the relevance of these findings in human macro-
phages, where NO generation appears to be more complex
and BH4 levels are lower (Fang and Vazquez-Torres, 2002; Leit-
ner et al., 2003; Schneemann and Schoedon, 2002; Schnee-
mann et al., 1993; Sharara et al., 1997; Vouldoukis et al.,
1995), and this requires thorough investigation in the future.
Nevertheless, we show that NO plays a unique and interesting228 Cell Reports 28, 218–230, July 2, 2019role in regulating the balance of the key metabolites itaconate,
succinate, and citrate, as well as the abundance of catalytic
Complex I subunits in murine macrophages.STAR+METHODS
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Anti-iNOS (1:1000) Abcam Cat# ab49999, RRID:AB_881438
Anti-GTPCH (1:5000) Prof. S. Gross, Cornell N/A
Anti-b-tubulin (1:20,000) Abcam Cat# 6046, RRID:AB_2210370
Anti-Ndufv2 (1:1000) Abcam Cat# ab183715, RRID:AB_2687934
Anti-HIF1a (1:500) Novus Cat# NB100-449, RRID:AB_10001045
Anti-hexokinase-2 (1:1000) Cell signaling Cat# 2867S, RRID:AB_2232946
Anti-IDH1 (1:1000) Cell signaling Cat# 8137S, RRID:AB_10950504
DuoSet ELISA IL-1b R&D systems Cat# DY401-05
DuoSet ELISA TNFa R&D systems Cat# DY410-05
DuoSet ELISA IL-6 R&D systems Cat# DY406-05
DuoSet ELISA IL-10 R&D systems Cat# DY417-05
Cis-aconitate decarboxylase (IRG1) antibody Eurogentec N/A
Chemicals, Peptides, and Recombinant Proteins
Interferon g PeproTech Cat# 315-05
Lipopolysaccharide Sigma Cat# L4391
Macrophage colony stimulating factor Peprotech Cat# 315-02
Granulocyte macrophage colony stimulating
factor
Peprotech Cat# 315-03
GSK864 Sigma SML1757
Critical Commercial Assays
Isocitrate dehydrogenase activity assay Abcam Cat# ab102528
Aconitase activity assay Abcam Cat# ab109712
Citrate assay kit Sigma MAK057
Deposited Data
Gchfl/flTie2cre Raw and normalized TMT data PRIDE PRIDE: PXD010628
Experimental Models: Organisms/Strains
Mouse: Nos2/ (Nos2tm1Lau) The Jackson Laboratory Cat#002609
Mouse: Gch1fl/flTie2cre N/A
Oligonucleotides
Taqman murine Il1b assay Applied biosystems Mm00434228_m1
Taqman murine Ndufv2 assay Applied biosystems Mm01239727_m1
Taqman murine Slc2a1 assay Applied biosystems Mm00441480_m1
Taqman murine Irg1 assay Applied biosystems Mm01224532_m1
Taqman murine Idh1 assay Applied biosystems Mm00516030_m1
Taqman murine Idh2 assay Applied biosystems Mm00612429_m1
Software and Algorithms
Cytoscape v3.6.0 https://cytoscape.org/
Graph Pad Prism 7 Graph Pad https://www.graphpad.com/
scientific-software/prism/
Other
Phenylmercury resin Gift from Professor Harry Ischiropoulos,
UPENN, USA
N/A
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LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to andwill be fulfilled by the LeadContact, DrMark J.
Crabtree (mark.crabtree@well.ox.ac.uk).
EXERIMENTAL MODEL AND SUBJECT DETAILS
In Vivo Models
Animal details
All animal procedures were approved and carried out in accordance with the University of Oxford ethical committee and the UK
Home Office Animals (Scientific Procedures) Act 1986. All procedures conformed with the Directive 2010/63/EU of the European
Parliament.
We have generated a Gch1 conditional knockout (floxed) allele using Cre/loxP strategy as described previously (Chuaiphichai et al.,
2014; McNeill et al., 2015). Gch1fl/fl animals were bred with Tie2cre transgenic mice to produce Gch1fl/flTie2cre mice where Gch1 is
deleted in endothelial cells and bone marrow-derived cells. The Tie2cre transgene is active in the female germline. Consequently, only
male animals are used to establish breeding pairs to maintain conditional expression. Experiments were performed using bone marrow
isolated from10-16weeksoldadultmaleand femaleGch1fl/flTie2cre (referred toasGchfl/flTie2cre)and theirGch1fl/fl (Gchfl/fl) littermateson
a pure (> 10 generations) C57BL6/J background. Mice were genotyped according to the published protocol (Chuaiphichai et al., 2014;
McNeill et al., 2015). Nos2/ (Nos2tm1Lau) (iNOS KO) and wild-type C57BL6/J mice were purchased from The Jackson Laboratory.
BCG intranasal infection
For intranasal (i.n.) infection, adult female mice (> 10-week old) were sedated using IsoFlo (Oxford University Veterinary Services; UK)
and inoculated with 53 106 CFU BCG through the nostrils (25 ml/nostril). Four weeks after infection, mice were sacrificed and lungs
were aseptically removed. Organs were homogenized in re-inforced tubes with ceramic beads containing 1 ml PBS using Precellys
24 (Stretton Scientific, UK). These samples were gathered as part of a previous study, and samples were reused for metabolic anal-
ysis to study the role of nitric oxide in metabolite accumulation accordingly (McNeill et al., 2015).
In vivo endotoxemia
Endotoxemia was induced under brief anesthesia (2% isoflurane; by air pump). Endotoxemia was induced in adult female mice
(> 10-week old) by intravenous injection into the tail vein of lipopolysaccharide (LPS; 12.5 mg/kg) from Salmonella typhimurium
(Sigma, L7261) as described previously. Mice were housed with access to a heating pad after injection. Prior to harvest, 24hrs
after injection, mice were anesthetized under isoflurane (2% by air pump), and core temperature was recorded by a rectal
probe. A venous blood sample was drawn from the inferior vena cava under terminal anesthesia for blood biochemistry. Blood
biochemistry was assessed immediately from 100 mL venous blood using a hand-held iSTAT point-of-care analyzer (Abbott
Laboratories), with EC8+ cartridges (Abbott Laboratories).
In Vitro Models
Culturing primary bone marrow derived macrophages
Bone marrow was obtained by flushing the femur and tibia of adult mice with PBS. A single cell suspension was prepared by passing
the bone marrow through a 70 mm cell strainer. Cells were then cultured on non-tissue culture treated plastic at 750,000 cells/well of
6 well plate or 3x106 cell/10 cm dishes for 7 days in DMEM:F12 (ThermoFisher Scientific) supplemented with penicillin (100 U/ml) and
streptomycin (100 ng/ml, Sigma), Ultra-low endotoxin fetal bovine serum (5%, Biowest), l-glutamine (5 mmol/liter, Sigma), and re-
combinant macrophage colony-stimulating factor (MCSF) protein (25ng/ml, Peprotech) at 37C and 5%CO2. On day 6 recombinant
granulocyte-MCSF (GMCSF) protein (50ng/ml, Peprotech) was added to the cells.
Stimulation of bone marrow-derived macrophages
Following differentiation cells were washed once with warm PBS and the media replaced with DMEM:F12 (ThermoFisher Scientific)
supplemented with penicillin (100 U/ml) and streptomycin (100 ng/ml, Sigma), Ultra-low endotoxin fetal bovine serum (2%, Biowest),
l-glutamine (5 mmol/liter, Sigma), MCSF (25ng/ml, Peprotech) and GMCSF (50ng/ml) before stimulation with IFNg (10 ng/ml, Pepro-
tech) and LPS (100 ng/ml, Sigma) for 16 hours, with parallel wells left unstimulated. Exceptionally, for extracellular flux assays cells
were re-plated onto tissue culture treated Seahorse XFe96 well plates 2 hours before stimulation. After 16 hours cell pellets, and cell
culture supernatants were collected, or the cells subjected to biochemical analysis.
For cells treated with NOC-12 (EMD Millipore, 487955) and 1400W dihydrochloride (Sigma, W4262), either 500 mM of NOC-12 or
10 mM of 1400W were added to media simultaneous to LPS/IFNg stimulation. Both NOC-12 and 1400W were solubilised with sterile
PBS to a stock concentration of 56.8mM and 40mM respectively.
METHOD DETAILS
Biopterin quantification by HPLC with electrochemical detection
BH4, BH2, and biopterin levels in cell and mitochondrial lysates were determined by HPLC followed by electrochemical and
fluorescent detection, as described previously. Macrophage pellets were resuspended in PBS (50 mmol/liter), pH 7.4, containinge2 Cell Reports 28, 218–230.e1–e7, July 2, 2019
dithioerythritol (1 mmol/liter) and EDTA (100 mmol/liter) and subjected to three freeze-thaw cycles. Following centrifugation (15 min at
17,000 g, 4C), the samples were transferred to new, cooled microtubes and precipitated with ice-cold extraction buffer containing
phosphoric acid (1 mol/liter), trichloroacetic acid (2 mol/liter), and dithioerythritol (1 mmol/liter). The samples were vigorously mixed
and then centrifuged for 15minutes at 17,000 g, 4C. The samples were injected onto an isocratic HPLC system and quantified using
sequential electrochemical (Coulochem III, ESA Inc.) and fluorescence (Jasco) detection. HPLC separation was performed using a
250mm, ACEC-18 column (Hichrom) andmobile phase comprising of sodium acetate (50mmol/liter), citric acid (5 mmol/liter), EDTA
(48 mmol/liter), and dithioerythritol (160 mmol/liter) (pH 5.2) (all ultrapure electrochemical HPLC grade), at a flow rate of 1.3 ml/min.
Background currents of +500 mA and 50 mA were used for the detection of BH4 on electrochemical cells E1 and E2, respectively.
7,8-BH2 and biopterin were measured using a Jasco FP2020 fluorescence detector. Quantification of BH4, BH2, and biopterin was
made by comparison with authentic external standards and normalized to sample protein content.
Western blotting
Cell lysates were prepared by homogenization in ice-cold CelLytic M buffer (Sigma) containing protease inhibitor cocktail
(Roche Applied Science). Lysates were centrifuged at 17,000 g for 10 minutes at 4C, and samples were prepared using LDS sample
buffer (Invitrogen). Western blotting was carried out using standard techniques with antibodies outlined in the Key Resources Table.
Exceptionally the IRG1 antibody (working concentration is 1:1000) is a polyclonal rabbit antibody custom made by Eurogentec Ltd
(Southampton) following rabbit immunisation and affinity purification.
NOx measurements
The levels of nitrite/nitrate (NOx) produced by bone marrow derived macrophages from Gchfl/flTie2cre and Gchfl/fl control mice were
determined using the CLD88 NO analyzer (Ecophysics), as previously described (McNeill et al., 2015). Briefly, media was collected
from activated and control BMDMs and stored at 80C for analysis. All samples were then thawed on ice, and NO liberation from
100 ul sample media (following chemical reduction by vanadium(III) chloride (VCl3) dissolved in HCl) was measured via a chemillu-
minescent reaction with ozone. Quantification of NOx accumulation was obtained by comparison with external standards and
normalized to protein concentration, determined by the bicinchoninic acid (BCA) protein assay.
Protein extraction and digestion
Cell pellets were lysed in RIPA buffer by freeze thawing on dry ice, and centrifuged at 17,000 g for 10 minutes at 4C. Extraction,
digestion and labeling of proteins were carried out using solutions prepared in triethylammonium bicarbonate buffer (TEAB,
1 mM). Dithiothreitol (DTT, 5 mM) was added to supernatants and incubated for 30 minutes at room temperature to reduce samples.
Iodoacetamide (20mM)was added and incubated for 30minutes at room temperature to alkylate samples before protein was precip-
itated out using a methanol/chloroform extraction method. In brief, relative to sample volumes, 3 volumes of methanol and 0.5
volumes of chloroform were added to samples and vortexed, before adding a further 2.25 volumes of water and vortexing again.
Samples were centrifuged at 17,000 g for 1 minute and the upper aqueous phase was removed. More methanol was added, and
samples were vortexed and centrifuged at 17,000 g for 2 minutes. Supernatants were discarded and the resulting protein pellet
was resuspended in urea (6 mol/liter) and subsequently diluted to 1 mol/liter urea with water. Sequencing grade modified trypsin
(Promega) was added at a ratio of 1:50 relative to protein content, and allowed to digest samples over night at 37C. The following
day formic acid (< 1%) was added to stop trypsinolysis, samples were desalted using C18 Sep-Pack cartridges (Waters), vacuum
dried (Speedvac, ThermoFisher Scientific) and stored at 80C.
Tandem Mass Tag (TMT)-labeling of peptides
Digested proteins were resuspended in TEAB (50mmol/liter). Peptide concentrations were determined using a PierceTM Quantitative
Colorimetric Peptide Assay kit (ThermoFisher Scientific) and calculated against a standard curve of known peptide concentrations
with a plate reader set at an absorbance of 490 nm. 100 ug of each sample was taken, made up to 100 ug/ul in TEAB (50 mM) and
labeled using TMT10plexTM Isobaric Label Reagent Sets (ThermoFisher Scientific) following the manufacturers protocol. TMT labels
were resuspended in acetonitrile, added to samples and incubated at room temperature for 1 hour. Hydroxylamine (5%) was added
for 15 minutes to quench the labeling reactions. The experimental design required 16 samples (4 each of untreated Gchfl/fl, untreated
Gchfl/flTie2cre, MLPS/IFNg Gchfl/fl and MLPS/IFNg Gchfl/flTie2cre) which were therefore split over 2x TMT10plexTM kits (8 samples in
each), with 2 labels used to link the sample sets and formed of identical pools containing equal quantities of all samples. Samples
labeled using Kit 1 and Kit 2 were pooled separately and desalted using C18 Sep-Pack cartridges (Waters), vacuum dried and stored
at 80C.
Mass spectrometric analysis of proteins
TMT-labeled peptides resuspended in 2% acetonitrile 0.1% trifluoroacetic acid were fractionated through an XBridge BEHC18 2.5um
XP column (Waters) using HPLC and a high pH fractionation protocol. Mobile phases consisted of water (pH 10, Buffer A) and aceto-
nitrile (90%, pH 10, Buffer B) and ran at 1% Buffer B for 12 mins, followed by a linear gradient to 35% Buffer B over 72 minutes and
finally 95% Buffer B for 10 minutes. Eluted peptides were collected every 2 minutes and concatenated at the end to form 8 fractions
which were vacuum dried and then resuspended in acetonitrile (2%) and TFA (0.1%). Fractions were analyzed by LC-MS/MS using aCell Reports 28, 218–230.e1–e7, July 2, 2019 e3
Dionex Ultimate 3000 nanoUPLC coupled to an Orbitrap Fusion Lumos mass spectrometer (Thermo Scientific). Peptides were sepa-
rated on a 50 cmEASY-Spray C18 column (75 mmx 500mm, 2 mmparticle size; ThermoScientific) over a 120minute gradient from2%
to 35% acetonitrile in 0.1% formic acid, 5% DMSO. The mass spectrometer was set to perform data-dependant acquisition in SPS-
MS3 mode with a cycle time of 4 s. Detailed mass spectrometer settings are listed in the table below.MS1
Detector Orbitrap, 120k
Scan range 380 - 1500 m/z
AGC target 200000
Injection time 50 ms
MS2
Detector IonTrap, Rapid
First mass 120
AGC target 10000
Injection time 50 ms
Isolation width 0.7 m/z
Fragmentation CID 35%
MS3
Detector Orbitrap, 60k
Scan range 120 - 500 m/z
AGC target 100000
Injection time 120 ms
SPS notches 3
Fragmentation HCD 65%Metabolomics
Cell were harvested and pellets immediately frozen on dry ice and stored at 80C prior to shipping to Metabolon on dry ice.
Metabolon measured metabolites using mass spectrometry, as outlined below.
Sample Preparation
Samples were prepared using the automated MicroLab STAR system from Hamilton Company. Several recovery standards were
added prior to the first step in the extraction process for QC purposes. To remove protein, dissociate small molecules bound to pro-
tein or trapped in the precipitated protein matrix, and to recover chemically diverse metabolites, proteins were precipitated with
methanol under vigorous shaking for 2 min (Glen Mills GenoGrinder 2000) followed by centrifugation. The resulting extract was
divided into five fractions: two for analysis by two separate reverse phase (RP)/UPLC-MS/MS methods with positive ion mode elec-
trospray ionization (ESI), one for analysis by RP/UPLC-MS/MS with negative ion mode ESI, one for analysis by HILIC/UPLC-MS/MS
with negative ion mode ESI, and one sample was reserved for backup. Samples were placed briefly on a TurboVap (Zymark) to
remove the organic solvent. The sample extracts were stored overnight under nitrogen before preparation for analysis.
Ultrahigh Performance Liquid Chromatography-Tandem Mass Spectroscopy (UPLC-MS/MS):
All methods utilized a Waters ACQUITY ultra-performance liquid chromatography (UPLC) and a Thermo Scientific Q-Exactive high
resolution/accurate mass spectrometer interfaced with a heated electrospray ionization (HESI-II) source and Orbitrap mass analyzer
operated at 35,000 mass resolution. The sample extract was dried then reconstituted in solvents compatible to each of the four
methods. Each reconstitution solvent contained a series of standards at fixed concentrations to ensure injection and chromato-
graphic consistency. One aliquot was analyzed using acidic positive ion conditions, chromatographically optimized for more hydro-
philic compounds. In this method, the extract was gradient eluted from a C18 column (Waters UPLC BEH C18-2.1x100 mm, 1.7 mm)
using water and methanol, containing 0.05% perfluoropentanoic acid (PFPA) and 0.1% formic acid (FA). Another aliquot was also
analyzed using acidic positive ion conditions, however it was chromatographically optimized for more hydrophobic compounds.
In this method, the extract was gradient eluted from the same afore mentioned C18 column using methanol, acetonitrile, water,
0.05% PFPA and 0.01% FA and was operated at an overall higher organic content. Another aliquot was analyzed using basic nega-
tive ion optimized conditions using a separate dedicated C18 column. The basic extracts were gradient eluted from the column using
methanol and water, however with 6.5mM Ammonium Bicarbonate at pH 8. The fourth aliquot was analyzed via negative ionization
following elution from aHILIC column (Waters UPLCBEHAmide 2.1x150mm, 1.7 mm) using a gradient consisting of water and aceto-
nitrile with 10mM Ammonium Formate, pH 10.8. The MS analysis alternated between MS and data-dependent MSn scans using
dynamic exclusion. The scan range varied slighted between methods but covered 70-1000 m/z. Raw data files are archived and
extracted as described below.e4 Cell Reports 28, 218–230.e1–e7, July 2, 2019
mtDNA quantification
DNA was extracted from macrophage cell pellets using QIAGEN blood and tissue kit according to manufacturer’s instructions.
DNA concentrations were measured by nanodrop and adjusted to 10ng/ml with nuclease free water. Quantification of mitochondrial
DNA copy number was performed by quantitative PCR of two nuclear encoded genes (Actb and Sdha), and two mitochondrially en-
coded genes (Cytb and mtCo2). Quantitative PCR reactions were prepared with 20ng of DNA, 1x iTAQ Universal SYBR Green
Supermix (Biorad), and 0.06ml of the relevant forward and reverse primers at 50mM concentration (ActbF – CTGCCTGACG
GCCAGG, ActR – GAAAAGAGCCTCAGGGCA, SdhaF – TACTACAGCCCCAAGTCT, SdhaR – TGGACCCATCTTCTATGC,
CytbF – CCACTTCATCTTACCATTTATTATCGC, CytbR – TTTTATCTGCATCTGAGTTTAATCCTGT, mtCo2F – CTACAAGACGC
CACAT, mtCo2R – GAGAGGGGAGAGCAAT) (Bailey et al., 2017). Final volume was adjusted to 10ml with nuclease free water.
PCR reaction was performed on Biorad CFX96 and was initiated at 95C for 4 minutes followed by 40 cycles of 95C for 5 s and
60C for 30 s. Mitochondrial DNA copy number was calculated by averaging the DCt values of each pair of genes (Actb versus
Cytb and Sdha versus mtCo2) in the calculation: mtDNA copy number = 2*((2^ (CtActb-CtCytb) + 2^ (CtSdha-CtmtCo2))/2).
Quantitative real-time RT-PCR
Total RNA was isolated using RNeasy kits (QIAGEN) and reverse transcribed to cDNA using QuantiTect Reverse Transcriptase
(QIAGEN). Quantitative real-time PCR was performed with 25 ng of cDNA on an iCycler IQ real time detection system (Bio-Rad Lab-
oratories Ltd., UK). Gene expression was determined using TaqMan Gene Expression Assays (Applied Biosystems, UK) relative to
the level of the house keeping gene GAPDH using real time RT-PCR.
Seahorse XFe96 analysis of mitochondrial function
On day 7 of culture macrophages were plated at a density of 83 104 cells per well into XFe96microplates. Cells were left to attach for
2 hours before stimulation with LPS/IFNg if required, for 16 hours. Extracellular flux analysis was then performed. One hour prior to
the assay, cells were washed and the culture medium was replaced with Seahorse XF Base Medium (modified DMEM with Phenol
Red, pH 7.4; Agilent), supplemented with glucose (10 mM, Sigma), glutamine (2 mM, Sigma), and sodium pyruvate (2 mM, Sigma),
before being incubated at 37C, at atmospheric CO2 levels. Oxygen consumption rate (OCR) and extracellular acidification rate
(ECAR) were measured using the XFe96 analyzer (Agilent). 3 base-line OCR measurements were taken followed by 3 measurements
after sequential injection of the following compounds from the XF Cell Mito Stress Test Kit (Agilent): oligomycin (2 mM, injection port
A), FCCP (2 mM, injection port B), and combined antimycin A (0.5 mM), and rotenone (0.5 mM) (injection port C). Cells were measured
in 10 replicate wells and all Seahorse was data normalized to cell number. For calculations (detailed in the table below) the third
reading in each case was used as the most stable point, with the exception of the highest reading following addition of FCCP.Respiratory function parameter Calculation
Basal OCR Base-line – Rotenone/antimycin A
ATP-linked OCR Base-line - Oligomycin
Maximal OCR FCCP - Rotenone/antimycin ASeahorse XFe96 analysis of glycolysis
Glycolytic activity was determined using the simultaneous ECAR readings generated during the above XF Cell Mito Stress Test, and
included the subsequent addition of 2-deoxyglucose (100 mM, Sigma) injected through port D. The third ECAR measurement
following the 2-deoxyglucose injection was subtracted from the third base-line ECAR reading to calculate ‘basal glycolysis’.
Second, the Seahorse XF Glycolytic Rate Assay protocol was used to generate a more robust measurement of glycolysis. Cells
were plated and stimulated as above for the XF Cell Mito Stress Test. One hour prior to the assay, cells were washed and the culture
medium was replaced with Seahorse XF Base Medium without Phenol Red (modified DMEM, pH 7.4; Agilent), supplemented with
glucose (10 mM, Sigma), glutamine (2 mM, Sigma), sodium pyruvate (1 mM, Sigma), and HEPES (5 mM, Agilent) before being incu-
bated at 37C, at atmospheric CO2 levels. Immediately prior to the assay this media was again replaced. 3 base-line OCR and ECAR
measurements were taken followed by 3 measurements after injection of combined antimycin A (0.5 mM), and rotenone (0.5 mM)
(injection port A, Mito Stress Test Kit), and 5 measurements after injection of 2-deoxyglucose (50 mM, Sigma). ECAR measurements
were converted into proton efflux rates (PER) andmitochondrial OCR (base-line OCR – rotenone/antimycin A) was used to determine
the PER attributed to glycolysis (glycoPER) and mitochondrial (mitoPER) acidification using the Agilent Seahorse XF Glycolytic Rate
Assay Report Generator and the Buffer (BF, 2.2) and CO2 contribution factors (CCF, 0.61) predetermined by Agilent.
Complex I activity assay
Complex I activity wasmeasured in mitochondria isolated using Qproteomemitochondrial isolation kit (QIAGEN). 25 mg of mitochon-
drial protein was resuspended in 1x native sample buffer (Invitrogen), 2% digitonin (supercomplexes) or 2% DDM (n-dodecyl-b-D-
maltoside) (isolated complex I), and 1x protease inhibitors (Roche) followed by 1 hour incubation on ice before final addition of 0.5%
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1x native cathode buffer followed by 90 minutes at 150 V in 0.1x native cathode buffer. Following electrophoresis, gels were incu-
bated in 150 mM NADH, 3mM nitro blue tetrazolium and 2 mM Tris at pH 7.4 for 3 hours.
Lactate assay
Extracellular lactate was determined using a Lactate-Glo assay kit (Promega, J5022). Media supernatants from 1x106 cells were
diluted at 1:50 in PBS and 50 mL were plated in duplicate in a 96-well plate. 50 mL of reaction mix containing lactate dehydrogenase,
reductase substrate, NAD, reductase and luciferin detection solution was then added. The resulting luminescence was measured on
a BMG microplate reader with an Endpoint of 50 minutes. Lactate levels were assessed using a lactate standard ranging from
1.56 mM to 200 mM. Final results were normalized using each samples protein concentration.
Measurement of itaconate using HPLC
Intracellular itaconic acid levels were measured using high performance liquid chromatography. Pellets from 1x106 macrophages
cells were resuspended in PBS, pH 7.4 and lysed by three freeze-thaw cycles. After centrifugation at 17,000 g for 15 minutes at
4C, debris-free lysates were transferred to new tubes. Proteins were then precipitated following addition of 100 mM of hydrochloric
acid and centrifuged at 17,000 g for 15 minutes at 4C. The remain supernatants were injected onto a column of 250 mm, ACE C-18
column (Hichrom) and itaconate was quantified using UV detection at 210 nm. HPLC separation was performed using amobile phase
comprising of 2.5% acetonitrile and 0.1% phosphoric acid (all ultrapure electrochemical HPLC grade), at a flow rate of 1.0 ml/min.
Quantification of itaconic acid was made by comparison with pure itaconic acid (Sigma, I29204) standard range from 0.50 mM to
500 mM. Final results were normalized using each samples protein concentration.
Isocitrate dehydrogenase activity assay
Isocitrate dehydrogenase (IDH) activity was determined for NADP+ dependent isoforms, IDH1 and IDH2, using a colorimetric IDH
Assay Kit (Abcam). In duplicate, cell lysates (7.5 mg) and NADPH standards were loaded into 96 well clear plates and incubated
with NADP+ and Isocitrate Substrate. NADPH production was recorded on a BMGmicroplate reader measuring OD450nm in an kinetic
assay with an Endpoint of 20 minutes. Endpoint results were used to calculate the amount of NADP in each well from a
standard curve, after averaging duplicates and subtracting blank values. IDH activity was determined using the following equation:
IDH activity = ðAmount of NADP=ðTime of reaction 3 Volume in wellÞÞ3 dilution factorAconitase activity assay
The cytosolic aconitase activity was determined using an enzyme activity assay kit (Abcam, ab109712). Cell pellets were lysed into
200 ml of cold assay buffer. After protein concentration determination, 70 mg of each cell lysate was assayed in duplicate into a 96well
UV plate provided and incubated with isocitrate and manganese. The conversion of isocitrate to cis-aconitate was immediately re-
corded by kinetic measurement at OD240nm for 30minutes with 60 s intervals and 3 s shaking between readings at room temperature.
As recommended by the manual, the resulting aconitase activity was determined by picking two points in a linear increasing interval:
Rate (OD/min) = (Absorbance1-Absorbance2) / Time (min).
Measurement of citrate accumulation
Following exposure of macrophages to GSK864, citrate was measured using a Citrate Assay Kit (Sigma) as per manufacturer’s
instructions.
Cytokine measurements by ELISA
DuoSet enzyme-linked immunosorbent assays (ELISAs) (R&D Systems) were used to measure TNF-a, IL-6, IL-10 and IL-1b in con-
dition media supernatants collected from macrophages re-plated at 1x106 cells per well of a 6 well plate on day 7 of culture and
stimulated with LPS/IFNg for 16 hours. To measure cytokines neat supernatants were used for IL-10 and IL-1b, and supernatants
were diluted 1:100 and 1:400 for TNFa and IL-6 respectively to allow comparison with standard curves. The day before the assay
Nunc-immuno 96 well plates (ThermoFisher Scientific) were pre-coated overnight at room temperature with Capture antibodies
(DuoSet) resuspended in PBS according to the manufacturer’s instructions. On the day of the assay plates were washed in
Wash Buffer (0.05% Tween20 in PBS) and blocked in Reagent Diluent (1% fatty acid free BSA (Sigma) in PBS) for 1 hour. After
further washing, samples and standards were added in duplicate (made up in Reagent Diluent/media as appropriate) and incu-
bated for 2 hours before additional wash steps. Detection antibodies (DuoSet) were added to wells and incubated for 2 hours
before additional wash steps. Wells were incubated with Streptavidin-HRP (DuoSet) for 20 minutes protected from light, and
then washed again. Substrate Solution (Substrate Reagent Pack, R&D Systems) was added, comprised of 1:1 mixture of Color
Reagent A and B, for 20 minutes protected from light. Stop Solution was added (0.67 N H2SO4) and plates were read on a
BMG microplate reader at 450 and 540 nm. For data analysis, 540 nm readings were subtracted from 450 nm values to correct
for optical imperfections in the plates, duplicate readings were averaged and blank optical densities subtracted from standards
and samples. Sample concentrations were calculated against standard curves generated using a four-parameter logistic
curve-fit, and multiplied by dilution factors if appropriate.e6 Cell Reports 28, 218–230.e1–e7, July 2, 2019
Peritoneal macrophage recruitment
For in vivo peritoneal recruitment experiments mice underwent intraperitoneal injected with 4% thioglycolate. 4 days later mice were
killed and the peritoneal cavity was lavagedwith 5 mL of PBS containing 5 mMEDTA.Macrophageswere plated into serological Petri
dishes in DMEM/F12 (with 2% FCS, Pen/Strep and Glutamine) and allowed to adhere for 75min. Adherent macrophages were har-
vested by washing the plates briefly with 2 PBS washes prior to detachment with ice cold PBS/5 mM EDTA then plated for cell acti-
vation assays. In vivomacrophages were stained with antibodies against CD45 (FITC), CD11b (PerCP) and F4:80 (APC) to assess the
purity of the population, specificity of the antibody staining was confirmed using isotype control antibodies stained with the same
fluorochromes (all antibodies and isotype controls Biolegend, UK). All flow cytometry was performed using a BD Fortessa X20 cy-
tometer and Diva software (BD Biosciences, Oxford, UK). Data was analyzed using Flow Jo software (TreeStar Inc, Wokingham, UK).
Organomercury enrichment and detection of S-nitrosated IDH by mass spectrometry
BMDMs were isolated, cultured and activated as described above. Phenylmercury resin (kindly provided by Professor Harry Ischir-
opoulos and Dr Paschalis Doulias, University of Pennsylvania, USA) was used to capture NO-Cys containing proteins, using mass
spectrometry as previously described.
Liquidchromatography tandemmassspectrometry (LC-MS/MS)wasperformedusinganOrbitrapVelosmassspectrometer, coupled
with a Waters nanoAquity UPLC. In brief, injected samples underwent online desalting using a Trap column Symmetry C18, 180 mm3
20 mm, 5 mmparticle,Waters). For separation, a BEHC18 column (75 mm3 250 mm, 1.7 mmparticle,Waters) was usedwith a flow rate
of250 nl/minover60 minutesandagradientof3%–40%acetonitrile0.1%Formicacid. Surveyscanswereacquired in theorbitrapwitha
resolution of 60,000 at 400 m/z between 300 and 2000m/z for up to 100 mswith an ion target of 1E6. Selected precursors were picked
above a threshold of 5E2 counts for MS/MS and excluded for 30 s after sampling. MS/MS spectra were acquired in the ion trap with a
maximum accumulation time of 100 ms and an ion target of 5E4 counts. CID fragmentation was performed with a normalized collision
energy of 35. Experiments were conducted in biological triplicates and all sample analyzed in a single sample batch.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis
All statistical analyses were carried out usingMicrosoft Excel (Microsoft) and GraphPad Prism 7 (GraphPad Inc.) software. Data were
expressed as mean ± standard error of the mean (SEM). A Student’s t test was used to compare two groups affected by one single
variable. Two-way ANOVA was used to compare multiple data groups affected by two independent variables, with Tukey’s post-test
to compare groups with each other. Differences were considered statistically significant at P values of * p < 0.05.
Proteomic data analysis
The data was analyzed in R using the default ‘‘stats’’ package for Analysis of Variance (ANOVA) and Tukey’s ‘Honest Significant
Different’ (TukeyHSD) package for post hoc test on all the proteins. The data comprised of 5,704 different proteins measured on
primary macrophages (n = 4) from Gchfl/fl and Gchfl/flTie2cre mice that were unstimulated or harvested following activation
with LPS/IFNg.We performed a two-way ANOVA comparing a panel of proteins inGchfl/flTie2cre against theGchfl/fl samples followed
by TukeyHSD method to create a set of confidence intervals based on the sample means. The proteins having a P-value < 9x106
(based on Bonferroni correction = 0.05/5704) were considered significant.
Enrichment analysis was carried out using the ClueGO app in Cytoscape (Ref), by searching gene names encoding proteins that
were considered statistically significant by and changed abundanceR 20%, against 4 data bases: Gene ontology (GO) Biological
Process (GO-BP), GO Cellular Component (GO-CC), GO Molecular Function (GO-MF) and Kyoto Encyclopaedia of Genes and Ge-
nomes (KEGG) pathways. Significantly enriched terms (p < 0.05) containingR 3 genes coveringR 4% of genes in that term were
used to create ClueGO Layouts, where each node represents a term (GO-BP, -CC and -MF are circular and KEGG are hexagonal)
and the size depends on the P value (smaller p = bigger node). GO term fusion was applied to merge nodes containing highly similar
genes, and terms were grouped into networks based on their kappa score level (R0.3). Nodes of the same color have overlapping
functional networks and the most significant term in each group was labeled with all others hidden for simplicity. All node/term in-
formation was downloaded together with names of the genes identified in our dataset that lead to enrichment, and these were
used to create heatmaps showing the scaled abundance of proteins encoded by these genes using Prism 7.
Metabolomic data analysis
Bioinformatics: The informatics system consisted of four major components, the Laboratory Information Management System
(LIMS), the data extraction and peak-identification software, data processing tools for QC and compound identification, and a collec-
tion of information interpretation and visualization tools for use by data analysts. The hardware and software foundations for these
informatics components were the LAN backbone, and a database server running Oracle 10.2.0.1 Enterprise Edition.
DATA AND CODE AVAILABILITY
Proteomics dataset is available on the PRIDE proteomics data repository: database accession number: PRIDE: PXD010628.Cell Reports 28, 218–230.e1–e7, July 2, 2019 e7
